Listed

Ecovyst Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 17, 2021 and accepted by EDGAR at May 17, 2021, 09:12 ET.

Share

Management's discussion and analysis

As filed, 54,488 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Unless the context requires otherwise, references in this report to “PQ Group Holdings,” “the company,” “we,” “us” or “our” refer to PQ Group Holdings Inc. and its consolidated subsidiaries.

Forward-looking Statements

This periodic report on Form 10-Q (“Form 10-Q”) includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements”. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short- and long-term business operations and objectives, and financial needs. Examples of forward-looking statements include, but are not limited to, statements we make regarding the announced pending sale of our Performance Chemicals segment, our financial results and our liquidity, including our belief that our existing cash, cash equivalents and cash flow from operations, combined with availability under our asset based lending revolving credit facility will be sufficient to meet our presently anticipated future cash needs for at least the next 12 months. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed herein may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Some of the key factors that could cause actual results to differ from our expectations include risks related to:

  • the impact of the ongoing COVID-19 pandemic on the global economy and financial markets, as well as on our business and our suppliers, and the response of governments and of our company to the outbreak;
  • as a global business, we are exposed to local business risks in different countries;
  • we are affected by general economic conditions and economic downturns;
  • exchange rate fluctuations could adversely affect our financial condition, results of operations and cash flows;
  • our international operations require us to comply with anti-corruption laws, trade and export controls and regulations of the U.S. government and various international jurisdictions in which we do business;
  • alternative technology or other changes in our customers’ products may reduce or eliminate the need for certain of our products;
  • our new product development and research and development efforts may not succeed and our competitors may develop more effective or successful products;
  • our substantial level of indebtedness could adversely affect our financial condition;
  • if we are unable to pass on increases in raw material prices, including natural gas, to our customers or to retain or replace our key suppliers, our results of operations and cash flows may be negatively affected;
  • we face substantial competition in the industries in which we operate;
  • we are subject to the risk of loss resulting from non-payment or non-performance by our customers;
  • we rely on a limited number of customers for a meaningful portion of our business;
  • multi-year customer contracts in our refining services segment are subject to potential early termination and such contracts may not be renewed at the end of their respective terms;
  • our quarterly results of operations are subject to fluctuations because demand for some of our products is seasonal;
  • our growth projects may result in significant expenditures before generating revenues, if any, which may materially and adversely affect our ability to implement our business strategy;
  • we may be liable to damages based on product liability claims brought against us or our customers for costs associated with recalls of our or our customers’ products;
  • we are subject to extensive environmental, health and safety regulations and face various risks associated with potential non-compliance or releases of hazardous materials;
  • existing and proposed regulations to address climate change by limiting greenhouse gas emissions may cause us to incur significant additional operating and capital expenses and may impact our business and results of operations;
  • production and distribution of our products could be disrupted for a variety of reasons, and such disruptions could expose us to significant losses or liabilities;
  • the insurance that we maintain may not fully cover all potential exposures;
  • we could be subject to damages based on claims brought against us by our customers or lose customers as a result of the failure of our products to meet certain quality specifications;
  • our failure to protect our intellectual property and infringement on the intellectual property rights of third parties;
  • losses and damages in connection with information technology risks could adversely affect our operations; and
  • other factors set forth in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020.

The forward-looking statements included herein are made only as of the date hereof. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-Q to conform these statements to actual results or to changes in our expectations.

Overview

We are a leading integrated and innovative global provider of specialty catalysts and services. We believe that our products, which are predominantly inorganic, and services contribute to improving the sustainability of the environment.

We conduct operations through two reporting segments: (1) Refining Services and (2) Catalysts (including our 50% interest in the Zeolyst Joint Venture).

Refining Services: We are the leading provider of sulfuric acid recycling services to North American refineries for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are also a leading North American producer of on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications.

Catalysts: We are a global supplier of finished silica catalysts and catalyst supports necessary to produce high strength and high stiffness plastics used in packaging films, bottles, containers, and other molded applications. We are also a leading global supplier of zeolites used for catalysts that remove nitric oxide from diesel engine emissions as well as sulfur from fuels during the refining process.

Recent Developments

On December 14, 2020, we completed the sale of our Performance Materials business for $650.0 million, which was subject to certain adjustments for indebtedness, working capital and cash at the closing of the transaction. The results of operations, financial condition, and cash flows for the Performance Materials business are presented herein as discontinued operations. Except where noted, any tables, percentages or metrics included within this filing exclude the results of our former Performance Materials business. Refer to Note 3 to our condensed consolidated financial statements for additional information.

On February 28, 2021, we announced the entry into a definitive agreement to sell our Performance Chemicals business to a partnership established by Koch Mineral & Trading LLC and Cerberus Capital Management, L.P. for a purchase price of $1.1 billion, which is subject to certain adjustments including for indebtedness, cash, working capital and transaction expenses. The results of operations, financial condition, and cash flows for the Performance Chemicals business are presented herein as discontinued operations. Except where noted, any tables, percentages or metrics included within this filing exclude the results of our Performance Chemicals business. Refer to Note 3 to our condensed consolidated financial statements for additional information.

Key Performance Indicators

Adjusted EBITDA and Adjusted Net Income

Adjusted EBITDA and adjusted net income are financial measures that are not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and that we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our competitors. Adjusted EBITDA and adjusted net income are presented as key performance indicators as we believe these financial measures will enhance a prospective investor’s understanding of our results of operations and financial condition. EBITDA consists of net income (loss) attributable to continuing operations before interest, taxes, depreciation and amortization. Adjusted EBITDA consists of EBITDA adjusted for (i) non-operating income or expense, (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) and EBITDA that we do not consider indicative of our ongoing operating performance, and (iii) depreciation, amortization and interest of our 50% share of the Zeolyst Joint Venture. Adjusted net income consists of net income (loss) attributable to continuing operations adjusted for (i) non-operating income or expense and (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) that we do not consider indicative of our ongoing operating performance. We believe that these non-GAAP financial measures provide investors with useful financial metrics to assess our operating performance from period-to-period by excluding certain items that we believe are not representative of our core business.

You should not consider adjusted EBITDA or adjusted net income in isolation or as alternatives to the presentation of our financial results in accordance with GAAP. The presentation of adjusted EBITDA and adjusted net income financial measures may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. In evaluating adjusted EBITDA and adjusted net income, you should be aware that we are likely to incur expenses similar to those eliminated in this presentation in the future and that certain of these items could be considered recurring in nature. Our presentation of adjusted EBITDA and adjusted net income should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Reconciliations of adjusted EBITDA and adjusted net income to GAAP net income (loss) are included in the results of operations discussion that follows for each of the respective periods.

Key Factors and Trends Affecting Operating Results and Financial Condition

Sales

Market demand has significantly rebounded since the 2020 lows that resulted from the impact of COVID-19. Refineries have seen demand return with increasing miles driven. Emission control and refining catalysts continue to lag, but show signs of rebound in the second half of 2021.

In February 2021, the Gulf Coast of the United States experienced significant and unexpectedly severe weather. Extended freezing temperatures led to shutdowns or slowdowns at nearly all refineries and extensive damage due to frozen piping. Some plants remained down for nearly a month. Our Refining Services facilities located in the Gulf experienced damage and required certain repairs.

Sales in our Refining Services and Catalysts segments are made on both a purchase order basis and pursuant to long-term contracts.

Cost of Goods Sold

Cost of goods sold consists of variable product costs, fixed manufacturing expenses, depreciation expense and freight expenses. Variable product costs include all raw materials, energy and packaging costs that are directly related to the manufacturing process. Fixed manufacturing expenses include all plant employment costs, manufacturing overhead and periodic maintenance costs. The primary raw materials for our Refining Services segment include spent sulfuric acid, sulfur, acids, bases (including sodium hydroxide, or “caustic soda”), and certain metals. The primary raw materials used in the manufacture of products in our Catalysts segments include sodium silicate and cesium hydroxide.

Most of our Refining Services contracts feature take-or-pay volume protection and/or quarterly price adjustments for commodity inputs, labor, the Chemical Engineering Index (U.S. chemical plant construction cost index) and natural gas. Spent acid for our Refining Services segment is supplied by customers for a nominal charge as part of their contracts. Over 80% of our Refining Services segment sales for the year ended December 31, 2020 were under contracts featuring quarterly price adjustments. The price adjustments generally reflect actual costs for producing acid and tend to protect us from volatility in labor, fixed costs and raw material pricing. The take-or-pay volume protection allows us to cover fixed costs through intermittent, temporary production issues at customer refineries.

While natural gas is not a direct feedstock for any product, natural gas powered furnaces are used to heat raw materials and create the chemical reactions necessary to produce end-products. We maintain multiple suppliers wherever possible, make forward purchases of natural gas in the United States and structure our customer contracts when possible to allow for the pass-through of raw material and natural gas costs.

Joint Ventures

We account for our investments in our equity joint ventures under the equity method. Our largest joint venture, the Zeolyst Joint Venture, manufactures high performance, specialty, zeolite-based catalysts for use in the packaging and engineered plastics, emission control, refining and petrochemical industries and other areas of the broader chemicals industry. We share proportionally in the management of our joint ventures with the other parties to each such joint venture.

Seasonality

Our Refining Services segment typically experiences seasonal fluctuations as a result of higher demand for gasoline products in the summer months and lower demand in the winter months. These demand fluctuations result in higher sales and working capital requirements in the second and third quarter.

Foreign Currency

As a global business, we are subject to the impact of gains and losses on currency translations, which occur when the financial statements of foreign operations are translated into U.S. dollars. We operate in various geographies with approximately 10% of our sales for the three months ended March 31, 2021 and the year ended December 31, 2020 are in currencies other than the U.S. dollar. Because our consolidated financial results are reported in U.S. dollars, sales or earnings generated in currencies other than the U.S. dollar can result in a significant increase or decrease in the amount of those sales and earnings when translated to U.S. dollars. The foreign currency to which we have the most significant exchange rate exposure is the British pound.

Results of Operations

Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31, 2020

Highlights

The following is a summary of our financial performance for the three months ended March 31, 2021 compared with the three months ended March 31, 2020.

Sales

  • Sales increased $1.0 million to $126.6 million. The increase in sales was primarily due to favorable cost pass-through pricing and higher polyethylene catalysts volumes offset by lower volumes of regeneration and virgin sulfuric acid.

Gross Profit

  • Gross profit decreased $7.6 million to $30.1 million. The decrease in gross profit was primarily due to lower sales volumes and an increase in manufacturing costs, which was partially offset by favorable customer pricing and product mix.

Operating Income

  • Operating income decreased by $9.4 million to $2.5 million. The decrease in operating income was due to a decrease in gross profit during the current year period.

Equity in Net Income of Affiliated Companies

  • Equity in net income of affiliated companies for the three months ended March 31, 2021 was $5.2 million, compared with $8.3 million for the three months ended March 31, 2020. The decrease of $3.1 million was due to a decrease in earnings generated by the Zeolyst Joint Venture for the three months ended March 31, 2021.

The following is our unaudited condensed consolidated statements of income and a summary of financial results for the three months ended March 31, 2021 and 2020:

(in millions, except percentages)

Three months ended March 31, 2021 2020 Change $%
Sales $126.6 $125.6 $1.0 0.8%
Cost of goods sold 96.5 87.9 8.6 9.8%
Gross profit 30.1 37.7 (7.6) (20.2)%
Gross profit margin 23.8% 30.0%
Selling, general and administrative expenses 22.1 22.3 (0.2) (0.9)%
Other operating expense, net 5.5 3.5 2.0 57.1%
Operating income 2.5 11.9 (9.4) (79.0)%
Operating income margin 2.0% 9.5%
Equity in net (income) from affiliated companies (5.2) (8.3) 3.1 (37.3)%
Interest expense, net 10.5 15.3 (4.8) (31.4)%
Debt extinguishment costs — 2.5 (2.5) (100.0)%
Other expense, net 5.1 7.5 (2.4) (32.0)%
Loss before income taxes and noncontrolling interest (7.9) (5.1) (2.8) 54.9%
Benefit for income taxes (5.2) (1.7) (3.5) 205.9%
Effective tax rate 65.4% 33.2%
Net loss from continuing operations (2.7) (3.4) 0.7 (20.6)%
Net (loss) income from discontinued operations, net of tax (89.8) 3.9 (93.7) NM
Net (loss) income (92.5) 0.5 (93.0) NM
Less: Net income attributable to the noncontrolling interest - discontinued operations 0.1 0.3 (0.2) (66.7)%
Net (loss) income attributable to PQ Group Holdings Inc. $(92.6) $0.2 $(92.8) NM

Sales

(in millions, except percentages)

Sales: Three months ended March 31, 2021 2020 Change $%
Refining Services $100.2 $100.7 $(0.5) (0.5)%
Catalysts 26.4 24.9 1.5 6.0%
Total sales $126.6 $125.6 $1.0 0.8%

Refining Services: Sales in Refining Services for the three months ended March 31, 2021 were $100.2 million, a decrease of $0.5 million, or 0.5%, compared to sales of $100.7 million for the three months ended March 31, 2020. The decrease in sales was due to lower sales volumes of $7.4 million partially offset by higher average selling prices of $5.8 million. The decline in sales volumes, estimated at $6.0 million, was a result of extensive damages to both our facilities and our customers facilities due to the freezing weather in the Gulf of Mexico. Higher average selling prices benefited from pass-through of favorable sulfur pricing of $3.1 million in our virgin sulfuric acid product group.

Catalysts: Sales in Silica Catalysts for the three months ended March 31, 2021 were $26.4 million, an increase of $1.5 million, or 6.0%, compared to sales of $24.9 million for the three months ended March 31, 2020. The increase in sales was primarily due to product mix of polyethylene catalysts resulting in an increase in pricing of $0.8 million.

Gross Profit

Gross profit for the three months ended March 31, 2021 was $30.1 million, a decrease of $7.6 million, or 20.2%, compared with $37.7 million for the three months ended March 31, 2020. The decrease in gross profit was due to lower sales volumes of $9.6 million and higher manufacturing costs of $7.0 million, which was partially offset by favorable customer pricing of $6.6 million and favorable product mix of $3.2 million.

Sales volumes declined within the fuels and emission control end uses as a result of extensive damages to both our facilities and our customers facilities due to the freezing weather in the Gulf of Mexico. The increase in manufacturing costs, estimated at $9.0 million, included one-time repair costs and higher inventory absorption costs. Favorable product mix was a result of increased sales of higher-margin polyethylene catalysts sales.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2021 was $22.1 million, a decrease of $0.2 million as compared to $22.3 million for the three months ended March 31, 2020. The decrease in selling, general and administrative expenses was due to the benefits of the transition service agreement entered into as part of the sale of the Performance Materials business, which was partially offset by increased stock compensation expense.

Other Operating Expense, Net

Other operating expense, net for the three months ended March 31, 2021 was $5.5 million, an increase of $2.0 million, compared with $3.5 million for the three months ended March 31, 2020. The increase in other operating expense, net was a result of severance charges incurred in the current year period.

Equity in Net Income of Affiliated Companies

Equity in net income of affiliated companies for the three months ended March 31, 2021 was $5.2 million, compared to $8.3 million for the three months ended March 31, 2020. The decrease was primarily due to $3.1 million of lower earnings from the Zeolyst Joint Venture during the three months ended March 31, 2021. The decline in earnings was a result of deferred change-outs related to reduced output from oil refineries and heavy duty vehicle production, which led to a decrease in demand for our emission control and hydrocracking catalysts.

Interest Expense, Net

Interest expense, net for the three months ended March 31, 2021 was $10.5 million, a decrease of $4.8 million, as compared with $15.3 million for the three months ended March 31, 2020. The decrease in interest expense was primarily due to lower interest rates on our variable debt offset by higher interest due on our interest rate caps.

Debt Extinguishment Costs

Debt extinguishment costs for the three months ended March 31, 2020 was $2.5 million. On February 7, 2020, we amended our existing senior secured term loan facility to reduce the applicable interest rates and extend the maturity of the facility to February 2027. We recorded $2.2 million of new creditor and third-party financing fees as debt extinguishment costs. In addition, previously unamortized deferred financing costs of $0.1 million and original issue discount of $0.2 million associated with the existing senior secured term loan facility were written off as debt extinguishment costs for the three months ended March 31, 2020.

Other Expense, Net

Other expense, net for the three months ended March 31, 2021 was expense of $5.1 million, a decrease of $2.4 million, as compared with expense of $7.5 million for the three months ended March 31, 2020. The change in other expense, net primarily consisted of a decrease in foreign currency losses for the three months ended March 31, 2021 as compared to foreign currency losses for the three months ended March 31, 2020. Foreign currency gains and losses are primarily driven by the fluctuations in our non-permanent intercompany debt denominated in local currency and translated to U.S. dollars.

Benefit for Income Taxes

The benefit for income taxes for the three months ended March 31, 2021 was $5.2 million compared to a $1.7 million benefit for the three months ended March 31, 2020. The effective income tax rate for the three months ended March 31, 2021 was 65.4% compared to 33.2% for the three months ended March 31, 2020.

The Company’s effective income tax rate fluctuates primarily due to income mix, the impacts of GILTI, discrete impacts of the divestiture of the Performance Chemicals business and changes in foreign exchange gains and losses, which create permanent differences in certain jurisdictions.

The difference between the U.S. federal statutory income tax rate and the Company’s effective income tax rate for the three months ended March 31, 2021 was mainly due to the impacts of GILTI, discrete tax impacts related to intraperiod allocation revaluation of deferred tax assets and liabilities as a result of the Performance Chemicals divestiture, and the tax effect of permanent differences related to foreign currency exchange gain or loss.

Net (Loss) Income Attributable to PQ Group Holdings

For the foregoing reasons and after the effect of the non-controlling interest in earnings of subsidiaries for each period presented, net loss attributable to PQ Group Holdings was $92.6 million for the three months ended March 31, 2021 compared with net income of $0.2 million for the three months ended March 31, 2020.

Adjusted EBITDA

Summarized Segment Adjusted EBITDA information is shown below in the following table:

(in millions, except percentages)

Segment Adjusted EBITDA:(1) Three months ended March 31, 2021 2020 Change $%
Refining Services $33.0 $37.2 $(4.2) (11.3)%
Catalysts(2) 18.5 22.7 (4.2) (18.5)%
Total Segment Adjusted EBITDA(3) 51.5 59.9 (8.4) (14.0)%
Unallocated corporate expenses (9.2) (11.3) 2.1 18.6%
Total Adjusted EBITDA $42.3 $48.6 $(6.3) (13.0)%

(1) We define Segment Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Our management evaluates the performance of our segments and allocates resources based primarily on Segment Adjusted EBITDA. Segment Adjusted EBITDA does not represent cash flow for periods presented and should not be considered as an alternative to net income as an indicator of our operating performance or as an alternative to cash flows as a source of liquidity. Segment Adjusted EBITDA may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.

(2) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $10.5 million for the three months ended March 31, 2021, which includes $5.2 million of equity in net income, excluding $1.7 million of amortization of investment in affiliate step-up plus $3.6 million of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $13.7 million for the three months ended March 31, 2020, which includes $8.3 million of equity in net income, excluding $1.7 million of amortization of investment in affiliate step-up plus $3.8 million of joint venture depreciation, amortization and interest.

(3) Our total Segment Adjusted EBITDA differs from our total consolidated Adjusted EBITDA due to unallocated corporate expenses. Rounding discrepancies may arise when rounding segment results from dollars (in thousands) to dollars (in millions).

Refining Services: Adjusted EBITDA for the three months ended March 31, 2021 was $33.0 million, a decrease of $4.2 million, or 11.3%, compared with $37.2 million for the three months ended March 31, 2020. The decrease in Adjusted EBITDA from lower volumes and higher repair costs to both our facilities and our customers facilities, estimated at $9.0 million, is related to unfavorable weather conditions in the Gulf of Mexico.

Catalysts: Adjusted EBITDA for the three months ended March 31, 2021 was $18.5 million, a decrease of $4.2 million, or 18.5%, compared with $22.7 million for the three months ended March 31, 2020. The decrease in Adjusted EBITDA was a result of lower fuels and emission control catalysts and unfavorable fixed cost absorption.

A reconciliation of net loss from continuing operations to Segment Adjusted EBITDA is as follows:

(in millions)

Reconciliation of net loss from continuing operations to Segment Adjusted EBITDA Three months ended March 31, 2021 2020
Net loss from continuing operations $(2.7) $(3.4)
Benefit for income taxes (5.2) (1.7)
Interest expense, net 10.5 15.3
Depreciation and amortization 19.5 18.7
EBITDA 22.1 29.0
Joint venture depreciation, amortization and interest(a) 3.6 3.7
Amortization of investment in affiliate step-up(b) 1.7 1.7
Debt extinguishment costs — 2.5
Net loss on asset disposals(c) 0.8 0.2
Foreign currency exchange loss(d) 5.1 7.1
LIFO benefit(e) (0.3) (1.7)
Transaction and other related costs(f) 0.5 0.8
Equity-based compensation 6.3 4.3
Restructuring, integration and business optimization expenses(g) 2.3 0.3
Defined benefit pension plan benefit(h) (0.6) (0.1)
Other(i) 0.8 0.8
Adjusted EBITDA 42.3 48.6
Unallocated corporate expenses 9.2 11.3
Segment Adjusted EBITDA $51.5 $59.9

(a) We use Adjusted EBITDA as a performance measure to evaluate our financial results. Because our Catalysts segment includes our 50% interest in the Zeolyst Joint Venture, we include an adjustment for our 50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.

(b) Represents the amortization of the fair value adjustments associated with the equity affiliate investment in the Zeolyst Joint Venture as a result of the combination of the businesses of PQ Holdings Inc. and Eco Services Operations LLC in May 2016. We determined the fair value of the equity affiliate investment and the fair value step-up was then attributed to the underlying assets of the Zeolyst Joint Venture. Amortization is primarily related to the fair value adjustments associated with fixed assets and intangible assets, including customer relationships and technical know-how.

(c) When asset disposals occur, we remove the impact of net gain/loss of the disposed asset because such impact primarily reflects the non-cash write-off of long-lived assets no longer in use.

(d) Reflects the exclusion of the foreign currency transaction gains and losses in the statements of income primarily related to the non-permanent intercompany debt denominated in local currency translated to U.S. dollars.

(e) Represents non-cash adjustments to the Company’s LIFO reserves for certain inventories in the U.S. that are valued using the LIFO method, which we believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.

(f) Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are completed, pending or abandoned, that we believe are not representative of our ongoing business operations.

(g) Includes the impact of restructuring, integration and business optimization expenses which are incremental costs that are not representative of our ongoing business operations.

(h) Represents adjustments for defined benefit pension plan (benefit) costs in our statements of income. All of our defined benefit pension plan obligations are under defined benefit pension plans that are frozen. As such, we do not view such income or expenses as core to our ongoing business operations.

(i) Other costs consist of certain expenses that are not core to our ongoing business operations, including environmental remediation-related costs associated with the legacy operations of our business prior to a business combination consummated in a prior year period and capital and franchise taxes. Included in this line-item are rounding discrepancies that may arise from rounding from dollars (in thousands) to dollars (in millions).

Adjusted Net Income

Summarized adjusted net income information is shown below in the following table:

(in millions)

Reconciliation of net loss from continuing operations to Adjusted Net Income(1)(2) Three months ended March 31, 2021 Pre-tax Tax expense (benefit) After-tax 2020 Pre-tax Tax expense (benefit) After-tax
Net loss from continuing operations $(7.9) $(5.2) $(2.7) $(5.1) $(1.7) $(3.4)
Less: Net income attributable to non-controlling interest - continuing operations — — — — — —
Net income attributable to PQ Group Holdings Inc. (7.9) (5.2) (2.7) (5.1) (1.7) (3.4)
Amortization of investment in affiliate step-up(b) 1.7 0.6 1.1 1.7 0.6 1.1
Debt extinguishment costs — — — 2.5 0.8 1.7
Net loss on asset disposals(c) 0.8 0.2 0.6 0.2 0.1 0.1
Foreign currency exchange loss(d) 5.1 1.4 3.7 7.1 2.3 4.8
LIFO benefit(e) (0.3) (0.1) (0.2) (1.7) (0.6) (1.1)
Transaction and other related costs(f) 0.5 0.1 0.4 0.8 0.3 0.5
Equity-based compensation 6.3 1.8 4.5 4.3 1.4 2.9
Restructuring, integration and business optimization expenses(g) 2.3 0.7 1.6 0.3 0.1 0.2
Defined benefit pension plan benefit(h) (0.6) (0.2) (0.4) (0.1) — (0.1)
Other(i) 0.8 0.4 0.4 0.8 0.2 0.6
Adjusted Net Income, including Intraperiod allocation $8.7 $(0.3) $9.0 $10.8 $3.5 $7.3
Intraperiod allocation for restating discontinued operations(3) — 2.9 (2.9) — — —
Adjusted Net Income $8.7 $2.6 $6.1 $10.8 $3.5 $7.3

(1) We define adjusted net income as net income attributable to PQ Group Holdings adjusted for non-operating income or expense and the impact of certain non-cash or other items that are included in net income that we do not consider indicative of our ongoing operating performance. Adjusted net income is presented as a key performance indicator as we believe it will enhance a prospective investor’s understanding of our results of operations and financial condition. Adjusted net income may not be comparable with net income or adjusted net income as defined by other companies.

(2) Refer to the Adjusted EBITDA notes above for more information with respect to each adjustment.

(3) Due to reporting the Performance Chemicals business as held for sale in discontinued operations, the estimated tax rate used to value deferred tax assets (“DTAs”) and deferred tax liabilities (“DTLs”) needs to be adjusted to remove the Performance Chemicals rate. Given it is a direct result of the sale of discontinued operations and the need to adjust the estimated tax rate arose because of discontinued operations, the impact of revaluing the reporting entity’s DTAs and DTLs are reflected in continuing operations. Due to this revaluation being solely as a result of the Performance Chemicals divestiture and a non-cash item, it is treated as an addback.

The adjustments to net income attributable to PQ Group Holdings Inc. are shown net of applicable tax rates of 28.8% and 32.5% for the three months ended March 31, 2021 and 2020, respectively, except for the foreign currency exchange loss and discrete impacts of the divestiture of the Performance Chemicals business.

Financial Condition, Liquidity and Capital Resources

Our primary sources of liquidity consist of cash flow from operations, existing cash balances as well as funds available under our asset based lending revolving credit facility. We expect that ongoing requirements for debt service and capital expenditures will be funded from these sources of funds. Our primary liquidity requirements include funding working capital requirements (primarily inventory and accounts receivable, net of accounts payable and other accrued liabilities), debt service requirements and capital expenditures. Our capital expenditures include both maintenance of business, which include spending on maintenance and health, safety and environmental initiatives as well as growth, which includes spending to drive organic sales growth and cost savings initiatives.

We believe that our existing cash, cash equivalents and cash flows from operations, combined with availability under our asset based lending revolving credit facility, will be sufficient to meet our presently anticipated future cash needs for at least the next twelve months. We may also pursue strategic acquisition or divestiture opportunities, which may impact our future cash requirements. We may, from time to time, increase borrowings under our asset based lending revolving credit facility to meet our future cash needs. As of March 31, 2021, we had cash and cash equivalents of $55.2 million and availability of $105.6 million under our asset based lending revolving credit facility, after giving effect to $17.8 million of outstanding letters of credit, for a total available liquidity of $160.8 million. We did not have any revolving credit facility borrowings as of March 31, 2021. As of March 31, 2021, we were in compliance with all covenants under our debt agreements.

Included in our cash and cash equivalents balance as of March 31, 2021 was $0.8 million of cash and cash equivalents held in foreign jurisdictions on a continuing operations basis. We repatriate cash held outside of the United States from certain foreign subsidiaries in order to meet domestic liquidity needs. Depending on domestic and foreign cash balances, we have certain flexibility to repatriate funds in order to meet those needs. Specifically, we have an intercompany loan structure in place with several of our foreign subsidiaries that allows us to repatriate foreign cash in a tax efficient manner from those subsidiaries. In certain cases, the repatriation of foreign cash under previous U.S. tax law had generally been subject to U.S. income taxes at the time of cash distribution. Due to the enactment of the TCJA in December 2017, future overseas earnings repatriation will generally no longer be subject to U.S. federal income taxes at the time of cash distribution. However, future foreign earnings may still be taxed for state income tax purposes, as well as subject to certain foreign withholding tax obligations, when cash amounts are distributed back to the U.S.

Our liquidity requirements are significant, primarily due to debt service requirements. As reported, our cash interest paid for the three months ended March 31, 2021 and 2020 was approximately $17.8 million and $19.8 million, respectively. Before any impact of hedges, a one percent change in assumed interest rates for our variable interest credit facilities would have an annual impact of approximately $11.3 million on interest expense. We hedge the interest rate fluctuations on debt obligations through interest rate cap agreements. As of March 31, 2021, we had interest rate caps on $500.0 million of notional variable debt with a cap rate of 0.84% through July 2022 and $400.0 million of notional variable-rate debt with a cap rate of 1.00% through August 2023.

Cash Flow

(in millions)

Continuing Operations Net cash provided by (used in): Three months ended March 31, 2021 2020
Operating activities $16.5 $11.1
Investing activities (54.5) (7.6)
Financing activities (1.5) 52.6
Discontinued Operations
Net cash provided by (used in):
Operating activities 0.9 (6.5)
Investing activities (22.0) (14.6)
Financing activities (0.5) 5.7
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2.7) (4.3)
Net change in cash, cash equivalents and restricted cash (63.8) 36.4
Cash, cash equivalents and restricted cash at beginning of period 137.2 73.9
Cash, cash equivalents and restricted cash at end of period 73.4 110.3
Less: cash, cash equivalents and restricted cash of discontinued operations (16.6) (53.4)
Cash, cash equivalents and restricted cash at end of period of continuing operations $56.8 $56.9

41

(in millions)

Continuing Operations Three months ended March 31, 2021 2020
Net (loss) income $(2.7) $(3.4)
Non-cash and non-working capital related activities(1) 27.7 22.0
Changes in working capital (4.3) (6.5)
Other operating activities (4.2) (1.0)
Net cash provided by operating activities, continuing operations $16.5 $11.1

(1) Includes depreciation, amortization, amortization of deferred financing costs and original issue discount, foreign currency exchange gains and losses, deferred income tax provision (benefit), net (gains) losses on asset disposals, stock compensation expense and equity in net income and dividends received from affiliated companies.

(in millions)

Continuing Operations Working capital changes that provided (used) cash: Three months ended March 31, 2021 2020
Receivables $(9.4) $(1.2)
Inventories 4.6 3.5
Prepaids and other current assets (2.2) (0.3)
Accounts payable 4.7 (3.1)
Accrued liabilities (2.0) (5.4)
$(4.3) $(6.5)

(in millions)

Continuing Operations Three months ended March 31, 2021 2020
Purchases of property, plant and equipment $(12.6) $(10.0)
Business combinations, net of cash acquired (42.0) —
Proceeds from sale of assets — 2.4
Net cash used in investing activities, continuing operations $(54.6) $(7.6)

(in millions)

Continuing Operations Three months ended March 31, 2021 2020
Net revolving credit facilities borrowings $— $59.0
Net cash borrowings (repayments) on debt obligations — (3.0)
Other financing activities (1.5) (3.5)
Net cash (used in) provided by financing activities, continuing operations $(1.5) $52.5

42

The following discussions related to our cash flows are presented on a continuing operations basis, which excludes the cash flows from our Performance Materials and Performance Chemicals businesses accounted for as discontinued operations. The discussion related to our adjusted free cash flow metric is presented on a consolidated basis.

Net cash provided by operating activities was $16.5 million for the three months ended March 31, 2021, compared to $11.1 million provided for the three months ended March 31, 2020. Cash generated by operating activities, other than changes in working capital, was higher during the three months ended March 31, 2021 by $3.4 million compared to the same period in the prior year. The change in working capital during the three months ended March 31, 2021 was favorable compared to the three months ended March 31, 2020. Cash used to fund working capital was $4.3 million and $6.5 million for the three months ended March 31, 2021 and 2020, respectively.

The increase in cash generated by operating activities, other than changes in working capital, was higher by $3.4 million as compared to the prior year period primarily due to an increase in dividends received from affiliated companies offset by a decline in operating profit.

The increase in cash from working capital of $2.2 million as compared to the prior year was primarily due to favorable changes in inventories, accounts payable and accrued liabilities which were partially offset by unfavorable changes in accounts receivable and prepaid and other current assets.

The increase in cash provided by inventory changes was due to the timing of sales orders for our polyethylene catalysts in the current year period and inventory build in the prior year period. The favorable change in accounts payable is due to the timing of capital spending and the favorable change in accrued liabilities relates to changes in various expense accruals. The unfavorable change in accounts receivable was driven by the timing of collections on receivable balances.

Net cash used in investing activities was $54.6 million for the three months ended March 31, 2021, compared to cash used of $7.6 million during the same period in 2020. Cash used in investing activities consisted of utilizing $12.6 million and $10.0 million to fund capital expenditures during the three months ended March 31, 2021 and 2020, respectively. During the quarter ended March 31, 2021, we acquired Chem32, LLC for $42.0 million. We received proceeds of $2.4 million related to the sale of non-core assets during the three months ended March 31, 2020.

Net cash used in financing activities was $1.5 million for the three months ended March 31, 2021, compared to net cash provided of $52.5 million during the same period in 2020. Net cash used in financing activities was primarily driven by $1.5 million of stock repurchases during the three months ended March 31, 2021. Net cash provided by financing activities was primarily driven by $59.0 million of net borrowings under our revolving credit facilities made through the three months ended March 31, 2020.

Adjusted Free Cash Flow

Adjusted free cash flow is a non-GAAP metric management reviews to gauge liquidity performance. Adjusted free cash flow is calculated as cash flow from operating activities less purchases of property, plant and equipment, adjusted for proceeds from the sale of assets, net interest proceeds on swaps designated as net investment hedges and the cash paid for costs related to segment disposals. For the three months ended March 31, 2021, adjusted free cash flow of $2.7 million was favorable to the prior year as cash flow from operating activities increased on a favorable change in working capital. Purchases of property, plant and equipment decreased as lower spending in discontinued operations was partially offset by higher maintenance of business capital in Refining Services.

(in millions)

Three months ended March 31, 2021 2020
Net cash provided by operating activities, continuing operations $16.5 $11.1
Net cash provided by operating activities, discontinued operations 0.9 (6.5)
Net cash provided by operating activities 17.4 4.6
Less:
Purchases of property, plant and equipment, continuing operations (12.6) (10.0)
Purchases of property, plant and equipment, discontinued operations (11.7) (18.1)
Purchases of property, plant and equipment(1) (24.3) (28.1)
Free cash flow (6.9) (23.5)
Adjustments to free cash flow:
Proceeds from sale of assets 0.3 2.4
Net interest proceeds on currency swaps 2.3 1.8
Cash paid for costs related to segment disposals 7.0 —
Adjusted free cash flow(2) $2.7 $(19.3)
Net cash used in investing activities(3) $(54.6) $(7.6)
Net cash used in financing activities $(1.5) $52.5

(1) Excludes the company’s proportionate 50% share of capital expenditures from the Zeolyst joint venture.

(2) We define adjusted free cash flow as net cash provided by operating activities less purchases of property, plant and equipment, adjusted for proceeds from sale of assets and net interest proceeds on swaps designated as net investment hedges and the cash paid for costs related to segment disposals. Adjusted free cash flow is a non-GAAP financial measure that we believe will enhance a prospective investor’s understanding of our ability to generate additional cash from operations, including the reduction in cash paid for interest related to our cross-currency interest rate swaps, and is an important financial measure for use in evaluating our financial performance. Our presentation of adjusted free cash flow is not intended to replace, and should not be considered superior to, the presentation of our net cash provided by operating activities determined in accordance with GAAP. Additionally, our definition of adjusted free cash flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments made for business acquisitions. Therefore, we believe it is important to view adjusted free cash flow as a measure that provides supplemental information to our consolidated statements of cash flows. You should not consider adjusted free cash flow in isolation or as an alternative to the presentation of our financial results in accordance with GAAP. The presentation of adjusted free cash flow may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures.

(3) Net cash used in investing activities includes purchases of property, plant and equipment, proceeds from sale of assets and net interest proceeds on swaps designated as net investment hedges, which are also included in our computation of adjusted free cash flow.

Debt

(in millions)

March 31, 2021 December 31, 2020
Senior Secured Term Loan Facility due February 2027 $671.7 $671.7
New Senior Secured Term Loan Facility due February 2027 459.7 459.7
5.75% Senior Unsecured Notes due 2025 295.0 295.0
ABL Facility — —
Total debt 1,426.4 1,426.4
Original issue discount (15.1) (15.6)
Deferred financing costs (9.7) (10.4)
Total debt, net of original issue discount and deferred financing costs 1,401.6 1,400.4
Less: current portion — —
Total long-term debt, excluding current portion $1,401.6 $1,400.4

As of March 31, 2021, our total debt was $1,426.4 million, excluding the original issue discount of $15.1 million and deferred financing fees of $9.7 million for our senior secured credit facilities and notes. Our net debt as of March 31, 2021 was $1,371.2 million, including cash and cash equivalents of $55.2 million. We may seek, subject to market conditions and other factors, opportunities to repurchase, refinance or otherwise reprice our debt.

Capital Expenditures

Maintenance capital expenditures include spending on maintenance of business, health, safety and environmental initiatives. Growth capital expenditures include spending to drive organic sales growth and cost savings initiatives. These capital expenditures represent our “book” capital expenditures for which the company has recorded, but not necessarily paid for the capital expenditures.

(in millions)

Three months ended March 31, 2021 2020
Maintenance capital expenditures $9.2 $7.2
Growth capital expenditures 2.6 2.3
Total capital expenditures $11.8 $9.5

Capital expenditures remained at a level sufficient for required maintenance and certain expansion growth initiatives during these periods. Maintenance capital expenditures were higher in the three months ended March 31, 2021 as compared to the three months ended March 31, 2020 due to higher spending on health and safety. Growth capital expenditures were in-line in the three months ended March 31, 2021 as compared to the three months ended March 31, 2020.

Pension Funding

We paid $0.0 million and $0.9 million in cash contributions into our defined benefit pension plans and other post-retirement plans during the three months ended March 31, 2021 and 2020, respectively. The net periodic pension expense was $0.6 million and $0.1 million for those same periods, respectively.

Off–Balance Sheet Arrangements

We had $17.8 million of outstanding letters of credit on our ABL Facility as of March 31, 2021.

Contractual Obligations

Information related to our contractual obligations at December 31, 2020 can be found in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 17, 2021, which we refer to as our Annual Report on Form 10-K. During the three months ended March 31, 2021, there have been no significant changes to our contractual obligations as disclosed in our Annual Report on Form 10-K.

Critical Accounting Policies and Estimates

We prepare our condensed consolidated financial statements in conformity with GAAP and our significant accounting policies are described in Note 2 to our audited consolidated financial statements included in our Annual Report on Form 10-K. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. We base our estimates and judgments on historical experience and other relevant factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We evaluate our critical accounting estimates, assumptions and judgments on an ongoing basis.

There has been no material change in our critical accounting policies and use of estimates from those described in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our Annual Report on Form 10-K.

Accounting Standards Not Yet Adopted

See Note 2 to our unaudited condensed consolidated financial statements for a discussion of recently issued accounting standards and their effect on us.

Market risk

As filed, 1,398 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our major market risk exposure is potential losses arising from changing rates and prices regarding foreign currency exchange rate risk, interest rate risk, commodity price risk and credit risk. The audit committee of our board of directors regularly reviews foreign exchange, interest rate and commodity hedging activity and monitors compliance with our hedging policy. We do not use financial instruments for speculative purposes, and we limit our hedging activity to the underlying economic exposure.

There have been no material changes in the foreign exchange risk, interest rate risk, commodity risk or credit risk discussed in Item 7A., “Quantitative and Qualitative Disclosures about Market Risk,” included in our Annual Report on Form 10-K. other than the following item:

Foreign Exchange Risk

In March 2021, as a result of the Performance Materials and Performance Chemicals divestitures, we settled our cross-currency swaps. At the date of settlement, the total notional value of the cross-currency swaps was $311.4 million. We paid $13.2 million in cash to settle the swaps, which is included in net cash used in investing activities, discontinued operations in our condensed consolidated statement of cash flows for the three months ended March 31, 2021, as the underlying subsidiary subject to the net investment hedging relationship is part of the Performance Chemicals business.

Controls and procedures

As filed, 1,997 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2021, the end of the period covered by this Quarterly Report on Form 10-Q.

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at a reasonable assurance level.

Changes in Internal Control Over Financial Reporting

No changes in our internal control over financial reporting occurred during the quarter ended March 31, 2021 that materially affected, or which are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 203 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

“Item 1A, Risk Factors” in our Annual Report on Form 10-K includes a discussion of our risk factors. There have been no material changes from the risk factors described in our Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$126.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$96.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-01-01 to 2021-03-31$30.1mus-gaap:GrossProfit
Selling, general and administrative3 months2021-01-01 to 2021-03-31$22.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31$2.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$10.5mus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31−$5.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$92.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.68us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31−$0.68us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-31136,006,082 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$17.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$12.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$55.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$369.2mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$3.06bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$192.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$1.88bnus-gaap:Liabilities
Long-term debtAt period end2021-03-31$1.40bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$0us-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-03-31$1.19bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001708035-21-000012. Last ingested by Listed: Nov 5, 2026, 16:25 ET. Listed shows no prices and gives no investment advice.